Baseline Characteristics of Patients With Follow-up MPS versus Patients Without
| Characteristic | No MPS (n = 271) | MPS (n = 476) | P |
|---|---|---|---|
| Female (%) | 23 | 21 | 0.5 |
| Age* (y) | 63 ± 11 | 63 ± 11 | 0.9 |
| Diabetes (%) | 17 | 19 | 0.5 |
| Hypercholesterolemia (%) | 76 | 78 | 0.6 |
| Hypertension (%) | 66 | 67 | 0.9 |
| Smoking (%) | 27 | 30 | 0.4 |
| Single-vessel (%) | 31 | 35 | 0.4 |
| Double-vessel (%) | 33 | 33 | 0.4 |
| Triple-vessel (%) | 36 | 32 | 0.4 |
| Left main (%) | 0.7 | 1.3 | 0.5 |
| Prior MI (%) | 30 | 26 | 0.2 |
| Acute ST-elevation MI (%) | 24 | 20 | 0.3 |
| Acute coronary syndrome (%) | 36 | 37 | 0.3 |
| Angina (%) | 40 | 44 | 0.3 |
| Referral from periphery (%) | 42 | 34 | 0.02 |
| Cypher stents (%) | 32 | 34 | 0.2 |
| Taxus stents (%) | 38 | 32 | 0.2 |
| Bare metal stents (%) | 30 | 34 | 0.2 |
| 2.5-mm stent only (%) | 24 | 29 | 0.14 |
| 3.5-mm stent only (%) | 31 | 23 | 0.02 |
| Number of stents per patient* | 1.4 ± 0.6 | 1.6 ± 0.7 | <0.0001 |
| Total length of stents (mm) per patient* | 31 ± 17 | 35 ± 22 | 0.006 |
↵* Data are mean ± SD.